African Diaspora Network Appoints Dr. Pierre Theodore to Board by
The African Diaspora Network (ADN) has expanded its leadership team with the appointment of Dr. Pierre R. Theodore as a member of its Board of Directors.
ADN, an organisation focused on connecting African diaspora talent, capital and expertise with opportunities across the continent, announced the appointment on September 18, 2026.
Dr. Theodore brings more than 20 years of experience in medicine, biotechnology, public health, investment and health equity to the organisation. He currently serves as Executive Director and Population Science Therapeutic Area Team Lead at Roche and Genentech. He is also a board-certified cardiothoracic surgeon and a member of the faculty at Stanford University.
His professional background spans clinical practice, academic medicine, healthcare venture capital and global health, giving him experience across both the scientific and business sides of healthcare.
Welcoming him to the board, ADN Chairman Josh Ghaim said Theodore’s background in biotechnology, global surgery and health equity would be valuable to the organisation as it enters an important phase of its development.
Theodore said he was pleased to join ADN and contribute to its efforts to harness the skills and influence of Africans in the diaspora.
He said the diaspora has an important role to play in Africa’s long-term development and that bringing together its collective expertise and resources can support sustainable progress across the continent.
The new board member joins a leadership team made up of professionals with experience in areas including science, law, venture capital, technology, healthcare and philanthropy.
Other members include ADN Chairman Josh Ghaim, Raj Aji, Dr. Josephine Fubara, Manoj Jain, Rick Levenson, Ndeye Makalou, ADN founder and CEO Almaz Negash, Innocent Shumba, Kedest Tesfagiorgis and Agnieszka Winkler.
The appointment comes as ADN continues to expand its operations. The organisation recently established a new office in Washington, D.C., as part of efforts to strengthen its engagement with diaspora communities, institutions and policymakers involved in U.S.-Africa relations.
According to ADN, the expansion is also part of its broader effort to encourage diaspora participation in Africa’s development beyond financial remittances.
ADN founder and CEO Almaz Negash described Theodore as an example of the type of professional expertise the organisation seeks to bring together.
She said his experience across science, industry and health equity would contribute to ADN’s work as it expands its reach and develops its capacity to support Africa and diaspora communities.
The organisation said Theodore’s addition to the board, alongside the opening of its Washington, D.C. office, reflects its plans to strengthen its leadership and broaden its engagement with the global African diaspora.
Comments